Le Lézard
Classified in: Health
Subjects: OBI, MAT

Delta 9 CFO Passes Away; Colleagues Pay Tribute to a Great Friend and Colleague


/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES./

WINNIPEG, Sept. 17, 2018 /CNW/ - It is with great sadness that Delta 9 Cannabis Inc. (TSXV: NINE) ("Delta 9" or the "Company") announces the passing of our colleague Brent Bottomley, the Company's Chief Financial Officer.

Brent Bottomley, Chief Financial Officer at Delta 9 Cannabis Inc., tragically passed away on Friday. (CNW Group/Delta 9 Cannabis Inc.)

Brent passed away suddenly while taking part in a bicycle trip in the United States. Delta 9 CEO John Arbuthnot said today that Brent's passing is a personal loss for everyone involved in Delta 9, and that all of the Company's staff members want to express their condolences to his family. "Brent was much more than just part of our management team," Arbuthnot said. "He joined our Company at a critical time in our development, when we were transitioning from a small startup in the cannabis industry to becoming a high growth company with more than a hundred employees. During that time, Brent was pivotal in acquiring the financing we needed to expand our business, and we leaned heavily on his vast experience as we grew our company."

Brent was central in the Company's successful financing efforts. At the same time, Brent was heavily involved in building out the Delta 9 management team and formulating its business plan. "Part of Brent's lasting legacy will be that he has positioned Delta 9 to succeed and grow," Arbuthnot said. "He helped build the foundation of this company as a leader in the cannabis industry and all of us at Delta 9 are determined that we will live up to his legacy. But Brent was more than just a great manager. He was a great friend to all of us and he will be missed more than any words can express."

Prior to joining Delta 9, Brent was a widely respected investment banker who held senior positions at Wellington West Capital Inc. and Merrill Lynch Canada and was a partner at Osprey Capital Partners.  He brought a depth of financial and public market experience to Delta 9 that Arbuthnot says was vital to the Company's rapid growth over the past two years.

"I know that I have leaned heavily on Brent for his wisdom and guidance since he joined our team," said Arbuthnot. "Today, thanks to his work, I can say that Delta 9 stands on a very solid financial foundation, is well funded for the anticipated legalization of recreational cannabis and we have comprehensive financial controls and accounting protocols in place."

Following Brent's passing, Jim Lawson will serve as interim Chief Financial Officer of Delta 9 until a permanent replacement can be found. Mr. Lawson has a lifetime of experience as a corporate accountant and is currently Controller at Delta 9. He has worked with the Company since it was founded in 2012.

About Delta 9 Cannabis Inc.
Delta 9 Cannabis was the fourth producer in Canada licensed to produce legal cannabis. Delta 9 now operates its wholly-owned subsidiary, Delta 9 Bio-Tech Inc., as a licensed producer of medical marijuana pursuant to the ACMPR and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 also owns 50 per cent of the 70,000 square foot Delta West facility in Alberta, and co-owns the Delta West Lifestyles cannabis retail operation. Delta 9's shares trade on the TSX Venture Exchange under the symbol "NINE".

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Delta 9 Cannabis Inc. (CNW Group/Delta 9 Cannabis Inc.)

SOURCE Delta 9 Cannabis Inc.


These press releases may also interest you

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...

at 17:49
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...

at 17:33
The American Association of Kidney Patients (AAKP), the oldest and largest independent kidney patient consumer organization in the United States, announced the overwhelming success of its 2024 "Are You O-K+" campaign, which marked May 1 (5.1) as...

at 17:21
The Jackson Laboratory (JAX), an independent, nonprofit biomedical research organization, and AbTherx, an innovator in biotechnology, announced a strategic partnership to develop and commercialize cutting-edge tools to expedite antibody discovery and...

at 17:00
Zepp Health Corporation ("Zepp" or the "Company") , a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange (the "NYSE") dated April 30, 2024, notifying Zepp that it is...



News published on and distributed by: